PamGene is a Dutch biotechnology company and offers research services with a unique and patented microarray platform for functional proteomics activity, profiling and cell signalling analysis. PamGene is developing biomarkers to predict therapy response for drug candidates and other active ingredients, as well as diagnostic applications for a number of immuno-oncological targets. PamGene’s microarray technology is used in a wide range of applications in pharmaceutical research and in (pre) clinical development to understand disease development and basic research.
